Cargando…

Novel biomarkers for the detection of prostate cancer

Prostate-specific antigen (PSA) is widely used as a biomarker in the detection of prostate cancer and for decision making regarding treatment options, response to therapy, and clinical follow-up. Despite its widespread use, it is well recognised that PSA has suboptimal performance as a screening too...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsen, Niels Asger, Hamdy, Freddie Charles, Bryant, Richard John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Changing Face of Prostate Cancer Diagnosis and Management
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356177/ https://www.ncbi.nlm.nih.gov/pubmed/28344810 http://dx.doi.org/10.1177/2051415816656121

Ejemplares similares

Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016)

The role of imaging in the diagnosis of primary prostate cancer
por: Harvey, Hugh, et al.
Publicado: (2016)

The role of chemotherapy and new targeted agents in the management of primary prostate cancer
por: Kumar, Sanjeev Srinivas, et al.
Publicado: (2016)

The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer
por: Gunner, Charlotte, et al.
Publicado: (2016)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
por: Andersson, Joel, et al.
Publicado: (2022)

Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer
por: Grochot, Rafael, et al.
Publicado: (2023)

Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617
por: Crumbaker, Megan, et al.
Publicado: (2023)

Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging
por: Zhong, Allison Y., et al.
Publicado: (2022)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
por: Aerts, Jan, et al.
Publicado: (2023)

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
por: Guldvik, Ingrid J., et al.
Publicado: (2020)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
por: Wänman, Johan, et al.
Publicado: (2022)

An E-mail interview with Prof. Shin-ichiro Kawazu
Publicado: (2016)

An E-mail interview with Dr. Nadira Karunaweera, Senior Professor and Chair, Head of Department Parasitology, Faculty of Medicine, University of Colombo, Sri Lanka
Publicado: (2016)

An E-mail interview with Prof. John Ackers
Publicado: (2014)

An e-mail interview with Dr. J. Mahanta
Publicado: (2012)

An interview with Dr. M. C. Agrawal
Publicado: (2013)

An interview with Dr. Magda Azab
Publicado: (2013)

An interview with Dr. T. M. Mohapatra
Publicado: (2014)

An E-mail interview with Prof. Jeremy S. Gray
Publicado: (2015)

An E-mail interview with Prof. John Horton
Publicado: (2015)

An E-mail Interview with Prof. Gagandeep Kang
Publicado: (2017)

An E-mail Interview with Prof. Aparup Das
Publicado: (2018)

An E-mail interview with Dr. Pradeep Das
Publicado: (2018)

An email interview with Dr. Christen Rune Stensvold
Publicado: (2019)

Migratory parasites esp larva migrans and its changing patterns
Publicado: (2020)

Face to face: Leishmaniasis and its changing patterns
Publicado: (2019)

Changing face of paragonimiasis
por: Blair, David
Publicado: (2020)

Face-to-Face: Virtual interview with Dr. Nirmal Kumar Ganguly
Publicado: (2021)

Face to face: Balantioides coli: A forgotten parasite
por: Silva Barbosa, Alynne Da
Publicado: (2021)

An E-mail interview with Prof. Shyam Sundar
Publicado: (2023)

An E-mail interview with Prof. Mohammed Hafeez
Publicado: (2023)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

Prostate Cancer Risk Inflation as a Consequence of Image-targeted Biopsy of the Prostate: A Computer Simulation Study
por: Robertson, Nicola L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k5fe1h7mhcm930pv26uv2orpmk